Reducing Streptococcal Testing in Patients <3 Years Old in an Emergency Department

A QI project aimed at reducing RSTs in the ED in patients aged <3 years. BACKGROUND: Although pharyngitis is common, group A Streptococcus is an uncommon etiology, and sequelae are rare in patients <3 years old. Inappropriate testing leads to increased cost of health care and unnecessary exposure to antibiotics. Rapid streptococcal tests (RSTs) for group A Streptococcus pharyngitis are not routinely indicated in this age group. At our urban, tertiary pediatric emergency department (ED), on average, 20 RSTs were performed each month for patients <3 years of age. Our objective was to reduce RSTs in the ED in patients aged <3 years by 50% in 18 months. METHODS: We initiated this project in October 2016 at an urban, tertiary pediatric ED. We surveyed pertinent multidisciplinary stakeholders to identify factors leading to RSTs in children <3 years of age. We conducted multiple interventions and collected weekly data on the number of RSTs in children aged <3 years (outcome measure) and the number of family complaints and return visits for complications of pharyngitis (balancing measure). We used statistical process control for analysis. RESULTS: The mean number of RSTs ordered per month in patients aged <3 years declined by 52% in 10 months. The majority of tests during the study phase were ordered by nurse practitioners (62%) for patients aged 25 to 36 months (66%). There has been 1 family grievance and no patient complications attributable to the project. CONCLUSIONS: Our interventions led to a successful and sustained reduction of RSTs in patients aged <3 years. A local clinical practice guideline was developed, and the project was expanded to other acute care settings.

[1]  A. Myers,et al.  Improving Guideline-Based Streptococcal Pharyngitis Testing: A Quality Improvement Initiative , 2018, Pediatrics.

[2]  L. Brammer,et al.  Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine , 2018, MMWR. Morbidity and mortality weekly report.

[3]  Daniel J. Shapiro,et al.  Viral Features and Testing for Streptococcal Pharyngitis , 2017, Pediatrics.

[4]  D. Mant,et al.  Antibiotic prescription strategies for acute sore throat: a prospective observational cohort study. , 2014, The Lancet. Infectious diseases.

[5]  A. Bisno,et al.  Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  N. Shaikh,et al.  Prevalence of Streptococcal Pharyngitis and Streptococcal Carriage in Children: A Meta-analysis , 2010, Pediatrics.

[7]  S. Saxena,et al.  Risk–benefit analysis of restricting antimicrobial prescribing in children: what do we really know? , 2010, Current opinion in infectious diseases.

[8]  D. Goldmann,et al.  Burden and Economic Cost of Group A Streptococcal Pharyngitis , 2008, Pediatrics.

[9]  Kwan Lee,et al.  Using control charts to assess performance measurement data. , 2002, The Joint Commission journal on quality improvement.

[10]  G. J. Langley,et al.  The improvement guide : a practical approach to enhancing organizational performance , 1996 .